As of June 2023 Galapagos NV has a market cap of $2.76 Billion. This makes Galapagos NV the world's 3312th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2023 | $2.76 B | -5.44% |
2022 | $2.92 B | -20.02% |
2021 | $3.65 B | -43.58% |
2020 | $6.47 B | -52.07% |
2019 | $13.50 B | 169.16% |
2018 | $5.01 B | 4.51% |
2017 | $4.80 B | 61.16% |
2016 | $2.97 B | 20.89% |
2015 | $2.46 B | 331.92% |
2014 | $0.57 B | -8.94% |
2013 | $0.62 B | 10.91% |
2012 | $0.56 B | 58.44% |
2011 | $0.35 B | -16.16% |
2010 | $0.42 B | 66.9% |
2009 | $0.25 B | 148.04% |
2008 | $0.10 B |
On Jun 1st, 2023 the market cap of Galapagos NV was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
![]() Johnson & Johnson JNJ | $401.60 B | 14,436.79% | ๐บ๐ธ USA |
![]() Abbott Laboratories ABT | $178.79 B | 6,371.89% | ๐บ๐ธ USA |
![]() AbbVie ABBV | $235.42 B | 8,421.63% | ๐บ๐ธ USA |
![]() Sanofi SNY | $126.03 B | 4,462.08% | ๐ซ๐ท France |
![]() Merck MRK | $281.47 B | 10,088.52% | ๐บ๐ธ USA |
![]() AstraZeneca AZN | $225.78 B | 8,072.49% | ๐ฌ๐ง UK |
![]() GlaxoSmithKline GSK | $69.32 B | 2,409.35% | ๐ฌ๐ง UK |
![]() Fortress Biotech
FBIO | $73.2 M | -97.35% | ๐บ๐ธ USA |
![]() Teva Pharmaceutical Industries TEVA | $8.09 B | 193.06% | ๐ฎ๐ฑ Israel |